% | $
Quotes you view appear here for quick access.

Albany Molecular Research Inc. Message Board

  • stk_hnter stk_hnter Nov 16, 2011 2:32 PM Flag

    amrithebest – what will happen to the plethora of compounds?

    AMRI Announces Third Quarter 2011 Results

    Press Release: AMRI – Thu, Nov 10, 2011 12:04 PM EST

    ALBANY, N.Y.--(BUSINESS WIRE)-- AMRI (NASDAQ: AMRI - News) today reported financial and operating results for the third quarter ended September 30, 2011.
    . . .
    Recent Highlights
    Recent noteworthy announcements or milestones at AMRI include the following:
    . . .
    ******** The decision to eliminate further development activities related to AMRI’s internal R&D programs, excluding its generic R&D program. The company will continue to pursue active partnership and out-licensing opportunities for the existing pipeline. ********

    Here is the full release:

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Ending internal R&D programs eliminates any hope for it to become a pharmaceutical company. Pipeline may get harder and harder to sell as time goes by because of the diminishing lifetime of any patents. Without any loyalty to burn, other chemistry CROs have closed their doors or moved abroad. So why would anyone think about any takeover?

      Does anyone know a chemistry CRO ever paid any dividends? So what is the value to buy this stock?

14.60+0.32(+2.24%)Aug 26 4:00 PMEDT